Filing metadata

Accession number
0001209191-21-021935
Form type
Form 4
Filer
NGM BIOPHARMACEUTICALS INC
CIK
CIK 1426332
Filed
Mar 18, 2021
Reporting period
Mar 17, 2021
Description
Insider transaction

Explore SEC Filings Hub